In 2019, WHO will ramp up work to eliminate cervical cancer worldwide by increasing coverage of the HPV vaccine, among other interventions.
New Year Resolutions: Ten health issues WHO will tackle this year
First trimester ondansetron exposure was not associated with an increased risk of overall congenital malformations or cardiac malformations after adjustment for known confounders.
First trimester ondansetron exposure was not associated with an increased risk of overall congenital malformations or cardiac malformations after adjustment for known confounders.
HIV in pregnancy
The United States Department of Health and Human Services (DHHS) recently updated its guidelines on the use of antiretroviral agents in pregnant women with HIV infection. Dolutegravir is newly listed as a preferred agent to initiate during the second and third trimester of pregnancy. However, the guidelines reiterate a conservative interim recommendation that dolutegravir not…
Omega-3 fatty acids and preterm birth (December 2018)
It has been hypothesized that maternal intake of omega-3 long-chain polyunsaturated fatty acids (n-3 PUFA) might reduce inflammation-mediated pregnancy disorders, such as spontaneous preterm birth.
The tumor necrosis factor inhibitor certolizumab pegol (CZP) is thought to be safe for use during pregnancy.
This biologic agent lacks the antibody Fc- region responsible for placental transfer of immunoglobulins.A recent analysis of the manufacturer’s pharmacovigilance database, representing the largest available cohort of exposed pregnant women (including over 300 women with rheumatic diseases and nearly 200 with Crohn disease), identified over 530 prospectively documented outcomes of maternal exposure. Over 80 percent…